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Abstract. Chimeric genes were created by fusing 
DNA sequences encoding the ectodomain of the influ- 
enza virus hemagglutinin (HA) to DNA coding for the 
transmembrane and cytoplasmic domains of either 
the G  glycoprotein of vesicular stomatitis virus or the 
gC glycoprotein of Herpes simplex virus 1. CV-1  cells 
infected with SV40 vectors carrying the recombinant 
genes expressed large amounts of the chimeric pro- 
teins, HAG or HAgC on their surfaces. Although the 
ectodomains of HAG and HAgC differed in their im- 
munological properties from that of HA, the chimeras 
displayed the biological functions characteristic of the 
wild-type protein. Both HAG and HAgC bound eryth- 
rocytes as efficiently as HA did and, after brief expo- 
sure to an acidic environment, induced the fusion of 
erythrocyte and CV-1 cell membranes. However, the 
behavior of HAG and HAgC at the cell surface dif- 
feted from that of HA in several important respects. 
HAG and HAgC were observed to collect in coated 
pits whereas wild-type HA was excluded from those 
structures. In the presence of chloroquine, which in- 
hibits the exit of receptors from endosomes, HAG and 
HAgC accumulated in intracellular vesicles. By con- 
trast, chloroquine had no effect on the location of 
wild-type HA. HAG and HAgC labeled at the cell 
surface exhibited a temperature-dependent acquisition 
of resistance to extracellular protease at a rate similar 
to the rates of internalization observed for many cell 
surface receptors. HA acquired resistance to protease 
at a rate at least 20-fold slower. We conclude that 
HAG and HAgC are efficiently routed into the endo- 
cytic pathway and HA is not. However, like HA, 
HAG was degraded slowly, raising the possibility that 
HAG recycles to the plasma membrane. 
I 
N most cell types endocytosis through coated pits is the 
major route by which cell surface proteins are internalized 
(2, 9, 22, 27). Coated pits have been estimated to occupy 
2% of the cell surface and, depending upon the cell type, can 
internalize membrane equivalent to 50 to 200% of the plas- 
malemma each hour (2, 22, 27, 38, 59, 60). Uptake of  proteins 
by this process is selective (2, 4, 22, 45, 60): certain surface 
proteins are apparently excluded from coated pits (8), and the 
presence  of a ligand can stimulate the specific removal of a 
particular  type  of receptor  from  the  cell  surface  whereas 
endocytosis of other plasma membrane proteins is unaffected 
(10, 36). The mechanisms responsible  for this selectivity are 
at present unknown. It has been variously proposed that a 
component of the coated pit binds a specific site on proteins 
destined to be internalized (4, 33, 45) or that aggregation  of 
surface proteins causes them to lodge in pits and be endocy- 
tosed (34, 38, 56). 
By  contrast  to  the  scanty information available  on  the 
nature of  the association between surface receptors and coated 
pits, the pathway followed by proteins after they are internal- 
ized is well known (9, 27, 60). In a process that requires only 
minutes, coated pits bud from the plasma membrane, lose 
their coats, and fuse with peripheral  endosomes (17, 26, 29, 
38, 43, 44). Here, proteins destined to return to the surface 
are  sorted from those that are  transported to  intracellular 
locations (6,  17,  28,  57,  69). Recycling of proteins  from 
endosomes to the cell surface is quite rapid, requiring only 5 
to 15 min (6, 7, 9, 57). Endosomes are acidic (3,  16, 39, 63, 
64),  and low  pH  is  required  for the  movement of many 
proteins from endosomes either to the cell surface (6, 23, 25, 
62) or to lysosomes (58). Agents that raise intracellular pH, 
such  as  chloroquine,  allow  uptake  of these  proteins  into 
endosomes but inhibit further transport (43). 
Recently it has  been  shown that in  the  absence  of the 
synthesis of other viral proteins, the G glycoprotein of vesic- 
ular stomatitis virus is efficiently endocytosed, enters endo- 
somes, and is recycled (40, 46-48; Gottlieb, T., M. Rindler, 
and D. D. Sabatini,  personal communication). Thus G pro- 
tein resembles cell surface receptors  and must contain some 
feature or features that cause it to be recognized  by coated 
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loma virus or SV40 vectors carrying a cloned cDNA gene (l 8, 
54), the hemagglutinin (HA),~ of the A/Japan influenza virus 
has a long lifespan on the cell surface and is internalized at a 
very low rate (Copeland, C., A. Helenius, I. Mellman, and J. 
Hearing, personal communication). Thus, HA is an example 
of a protein that appears to be excluded from the endocytic 
pathway. Exclusion of HA might occur through interactions 
between HA  and an element of the cell  surface that is an- 
chored in some way, or might be due to the lack of a specific 
signal required for internalization through coated pits.  If this 
latter possibility is the case, then transfer of an "internalization 
signal" to HA should target HA for endocytosis. 
We wished to determine whether the transmembrane and 
cytoplasmic  domains  of G  protein  contained  features that 
could direct the external domain of HA into coated pits. To 
accomplish this, we constructed a chimeric gene in which the 
translational reading frame for the HA ectodomain was joined 
to that of the transmembrane and cytoplasmic domains of G 
protein.  Previously  we  had  constructed  a  chimera  with  a 
similar structure fusing HA sequences to those of the HSV-l 
glycoprotein C and had demonstrated that the hybrid protein 
reached the cell surface (21).  We have now expressed these 
genes  in  simian  cells infected  with  SV40  vectors and have 
investigated  the  influence  of the  foreign  domains  on  the 
interaction of HA with the endocytic pathway. 
Materials and Methods 
Enzymes and Reagents 
Restriction enzymes and  DNA  ligase  were  purchased  from  New  England 
Biolabs (Beverly, MA); T4 polymerase  from P-L Biochemicals, Inc. (Milwaukee, 
WI); lactoperoxidase  and calf intestinal phosphatase from  Boehringer  Mann- 
heim Biochemicals (Indianapolis, IN); reagents for polyacrylamide  electropho- 
resis  from  Bio-Rad  Laboratories (Richmond,  CA);  fluorescent  and  ferritin- 
conjugated  antibodies from  CooperBiomedical,  Inc.  (Malvern,  PA);  and re- 
agents for electron microscopy from Polysciences, Inc. (Warrington, PA). Other 
chemicals were purchased  from Sigma Chemical Co. (St. Louis, MO). 
Construction of Chimeric Glycoprotein Genes 
Recombinant DNA techniques were those described  by Maniatis et al. (15). A 
pBR322  plasmid containing an EcoRI-BamHI fragment of HSV-1 gC DNA 
(0.633  to 0.643)  was  obtained from  E.  K.  Wagner (37). This plasmid was 
digested with Pvul, at a site four nucleotides  upstream from sequences encoding 
the hydrophobic amino acids of the gC transmembrane domain. To adjust the 
translational  reading frame of the gC sequence with that of a sequence encoding 
the  HA  ectodomain, the two nucleotide 3'  extension at the  Pvul site  was 
removed with T4 polymerase.  The gC plasmid was then digested with Sail at a 
site outside the gC gene and a fragment was isolated containing gC sequences 
from  nucleotide 1692 at the Pvul site to a BamHl site at nucleotide 2208 in 
the 3' noncoding region.  Plasmid Xf3 (15) was digested with BamHl, treated 
with the Klenow fragment of DNA polymerase I to fill the recessed ends, and 
digested with Sail. The Pvul-Sall fragment containing the gC 3' sequences was 
inserted  between  the Sail  and  filled  BamHl sites  of Xf3  and bacteria were 
transformed with the ligation mixture (24). Colonies were selected containing 
plasmids in which blunt-end ligation of gC  nucleotide  1692 to  the altered 
plasmid BamHl site had re-formed the BamHl site. Digestion of these plasmids 
with Bam Hl released a 514-bp fragment which was cloned into M l3mp8 and 
sequenced  by  the dideoxy chain termination method (55),  confirming the 
correct  positioning of  the  reconstructed  BamHl  site.  The  SV40  vector 
SVEHA20-A-  (19) containing a truncated gene encoding a  secreted  form of 
HA, (HA M) was cloned into pKSB- (12) through the unique SV40 Kpnl site. 
The resulting plasmid, pKSVEHA ~, was linearized with BamH! at a unique 
Abbreviations used in this paper." DME, Dulbecco's modified Eagle's medium; 
HA, hemagglutinin; NET/GEL,  150 mM NaCI, 50 mM Tris, pH 8.0,  1 mM 
EDTA, 0.25% gelatin, 0.05% Nonidet P-40, 0.01% NAN3. 
site at the 3' end of the HA  W gene, and the BamHl fragment containing the 
gC sequences was inserted. The orientation of the BamHI gC fragment relative 
to  the  HA  sequences  was  determined by  restriction  enzyme analysis and 
plasmids with the correct orientation were isolated as the series pkSVEHAgC. 
DNA coding for the VSV G  protein was obtained from  J.  Rose (51), and 
nucleotides 1381 to  1665 (encoding  the transmembrane and cytoplasmic do- 
mains of G protein) were isolated as a TaqI to BamHl fragment.  In the course 
of previously  reported  experiments (12) we constructed M I3-HA derivatives 
each having a Clal linker inserted  into HA sequences encoding the carboxy- 
terminal one-third of the  HA  protein.  We identified a  recombinant phage, 
mpHA351,  in which the position of the inserted Clal site at nucleotide 1590 of 
the HA sequence (20) allowed fusion of the authentic HA reading frame with 
that  of the  G  sequences  in  the  isolated TaqI-BamHl  fragment.  The  HA 
sequences in mpHA351  between the Clal and BamHl sites were replaced with 
the G sequences on the Taql-BamHI fragment.  Correct  fusion of the HA and 
G  sequences  in mpHAG was confirmed by DNA  sequencing (55). HA  se- 
quences in the vector pkSVEHA  were replaced with the analogous sequences 
from mpHAG to create pkSVEHAG. 
Generation of  Recombinant SV40 Stocks 
Several isolates of pkSVEHAG and pkSVEHAgC  were selected and digested 
with Kpnl. Viral sequences were isolated from plasmid sequences, recircular- 
ized, and introduced into CV-I cells with an equal amount of D11055  helper 
virus DNA (49). Virus stocks were prepared and assayed for HA production as 
previously  described  (12,  18,  55). No  significant differences  were  observed 
between independently derived stocks of the same recombinant virus. 
Hemagglutination and Cell Fusion Assays 
At 36 to 40 h after infection with recombinant viruses, CV-I cells were overlaid 
at 23"C with a  1% solution of washed guinea pig erythrocytes  in PBS. After  10 
min unbound cells were removed by washing and the cells were photographed 
with a Nikon diaphot inverted microscope. Cell fusion induced by low pH was 
assayed by the procedures  of Doxey et al.  (11). In brief,  human erythrocyte 
ghosts  loaded with horseradish  peroxidase  were  allowed  to  bind to  vector- 
infected  cells  which  had  been  previously  treated with  10 ~g/ml trypsin in 
Dulbecco's  modified Eagle's  medium  (DME)  at  37"C to  cleave  HA.  The 
medium containing trypsin was replaced with medium buffered to pH 4.8-5.0. 
After several rain this medium was replaced with DME at pH 7.2 and the cells 
were left at 37"C for 1 h to allow the peroxidase to diffuse from the erythrocytes 
into the CV-I cells. The cells were fixed with 1% glutaraldehyde,  stained with 
diaminobenzidine, and photographed. 
Immunofluorescence and Electronmicroscopy 
After  30-36 h, cells infected  with SV40-HA  recombinant viruses were  fixed 
with 2% formaldehyde  and 0.1%  glutaraldehyde for surface labeling, or with 
formaldehyde alone if  they were to be permeabilized.  The fixative was quenched 
with 20 mM ammonium chloride in PBS (5). For surface labeling, nonspecific 
adsorption of the fluorescent  antibody was blocked by treating fixed cells for 
30  min in PBS  containing 1.0% rehydrated skim milk, and all subsequent 
washes and incubations with antibodies were performed  with this solution.  For 
intracellular  labeling, fixed cells were treated with 1.0% Triton X-100 in NET/ 
GEL 150 mM NaCI, 50 mM Tris, pH 8.0, 1 mM EDTA, 0.25% gelatin, 0.05% 
Nonidet P-40,  0.01%  NaN3 for  15  min.  Subsequent  washes  and  antibody 
incubations were performed  with NET/GEL from which the Triton X-100 had 
been omitted. Cells were observed and photographed  with a Leitz Ortholux 11 
microscope  fitted with N2 and L2 filters and an Orthomat W camera. 
For electron microscopy,  cells were fixed and reacted with anti-HA IgG as 
described for immunofluorescence and then labeled with a ferritin-conjugated 
goat anti-rabbit lgG.  After  labeling,  monolayers of cells were fixed with  1% 
glutaraldehyde for '30 min and postfixed with 1% osmium tetroxide for I h at 
4"C. After dehydration through 70, 90, and 100% ethanol, cells were removed 
from the plastic culture dish by dissolving  the plastic in propylene oxide (53). 
The sheets of monolayer released from the plastic were collected in glass tubes, 
washed twice with propylene oxide and impregnated with Polybed (Polysciences 
Inc.).  Cells  in  liquid polybed  were  placed  in  Beem  capsules,  inserted  into 
microfuge  tubes,  and  heated  to  40°C for  10  min to make the polybed  less 
viscous.  The cell sheets  were  spun to the bottom of the Beem capsule  in a 
microfuge and the plastic hardened at 60"C overnight.  Thin sections were cut 
using a Sorvall M2-B microtome (Dupont Instrument Co., Wilmington, DE), 
stained with uranyl acetate and lead citrate, and mounted on 300 mesh copper 
grids. Samples were photographed with a Philips 201 electronmieroscope. 
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Vector-infected cells were metabolically  labeled with [3SS]methionine at 30-36 
h after infection as previously  described  (12). Cell surfaces were labeled with 
~ZSl at 0°C using  lactoperoxidase  and glucose oxidase  (30).  To assay for the 
acquisition  of temperature-dependent resistance to trypsin, cells that had been 
labeled with ~251 at 0*C were washed extensively and placed at 37"C in DME 
for various  intervals.  After the 37"C chase periods, the cells were placed  into 
ice-cold DME containing 10 mM Hepes, pH 7.2, and 100 ug/ml trypsin for 1 
hr. At the end of  this period the trypsin was removed and the cells were washed 
five times during 30 min with DME containing 10% calf serum. Samples were 
scraped into 50 mM Tris, pH 8.0,  1.0% Nonidet P-40,  1 mM p-hydroxymer- 
curibenzoate,  containing 0.1 U aprotinin and 10 ,g a-macroglobulin/ml. After 
removal of nuclei and large debris by centrifugation  at 10.000 g for 10 min, an 
equal  volume of NET/GEL was added to the cell lysates, and samples were 
immunoprecipitated. 
Results 
Structure of  HAG and HAgC 
The HA, G, and gC polypeptides each have a large external 
domain, a single hydrophobic transmembrane domain, and a 
short  carboxy-terminal cytoplasmic region  (Fig.  1).  Genes 
coding for chimeric glycoproteins were constructed such that 
DNA encoding the large external domain of HA was joined 
in  translational reading frame to that coding for the trans- 
membrane and cytoplasmic domains of G  or gC (see Fig.  1 
and Materials and Methods for details).  The predicted amino 
acid sequences for the transmembrane and cytoplasmic do- 
mains of the resulting chimeras are shown in Fig.  1. Analysis 
of the A/Japan HA sequence with the hydropathy program 
of Kyte and Doolittle (32) indicates that the transmembrane 
domain  of HA  begins  within  one  or  two  amino  acids  of 
glutamine  525.  The HAG protein consists of the first 516 
residues of HA, two new residues contributed by a synthetic 
linker used in cloning, and carboxy-terminal sequences from 
G. The HAgC protein consists of 524 amino acids of the HA 
ectodomain, a  pentapeptide of novel sequence, and the gC 
transmembrane  and  cytoplasmic domains.  Also shown  for 
comparison in Fig. 1 are the sequences of  the parent molecules 
from which the chimeras were derived. 
As  a  consequence  of their  construction,  both  chimeric 
proteins  contain  changes  in  the  ectodomain  close  to  the 
boundary with the transmembrane domain. To establish  that 
changes in this portion of  the HA ectodomain have little effect 
on HA function, HA351, the direct precursor for HAG, was 
included as a control in all of the experiments with the two 
chimeric proteins.  In  HA351,  five amino  acids  have been 
deleted and two new residues inserted into the HA ectodo- 
main at a position four residues from the ectodomain-trans- 
membrane domain boundary (Fig.  i).  In all  of the experi- 
ments  described below  HA351  was  both  functionally and 
antigenically equivalent to wild-type HA. Thus, changes can 
be introduced into this region of the HA ectodomain without 
observable effect. 
Expression of  Functional HAG and HAgC 
Glycoproteins from Recombinant SV40 Vectors 
Recombinant  virus  stocks  SVEHAG,  SVEHA351,  or 
SVEHAgC were developed by the procedure described previ- 
ously (12). Fresh virus stocks of the vector carrying the wild- 
Transmembrane  Figure  1.  The  HA,  HAG,  and 
~ ~  ~domain  jl  Cytoplasmic 
I  Ectodomain  1  /  domain  I  HAgC  polypeptides  consist  of 
,  three  topological  domains.  The 
NH 3  HA I  HA  2  '  topographic orientation of the lin- 
HA  I  I  I  ]  T  I  I  I  COOH  ear amino acid sequences of HA, 
HAl  HA2G  )  HAG, and HAgC are diagrammed 
[~  to scale. The boxed areas indicate 
HAG  I  I  I  I  ~  I  I~J,  ,  the  hydrophobic  residues  pre- 
dicted to span the lipid bilayer by  HA I  HA2gC  I 
HAoC  I  I  I  I  0  I  I  ~"1  hydropathy  analysis (32).  To  the 
IO0  200  5  0 T  400  500,  ,  left of  the boxed region extendsthe 
cleavage  '  large amino-terminal external do- 
site  main.  A  unique  trypsin  sensitive 
site is indicated at which the HA 
BI  EIKGVKLSSNGVYO[ILAIYATVAGSLSLAIMMAGISFWMC~NGSLOCRICl  ectodomain  can  be  cleaved  into 
HA~  and  HA2  subunits.  To  the 
right  of  the  hydrophobic  trans-  HA.35|  EIKGVXD  GVYQ[ILAIYATVAGSLSLAI  MMAG  IS  FWMC~NGSLQCR  I  C[ 
membrane  domain  are  residues 
HAG  EIKGVIOLVEGMFSSM~SIISFFFIIGLIIGLF~LV~VGIHLCIKLKHTRKROIITDI£~MILGK  exposed  to  the  cytoplasm.  Car- 
I  boxy-terminal  amino  acid  se- 
¥-~¥  G  LSKNPIELVEGWFSSWK~SIASFFFIIGLIIGLFLVL~VGIHLCIKLKHTKKRQIYTDIEMNRLGK  quences  of parent,  mutant,  and 
chimeric  glycoproteins  are  dis- 
played  below  the  diagram.  The 
nA  EIKGVKLSSMGVYQ[ILAIYATVAGSLSLAIMMAGISFWMC~NGSLQCRICl  construction of  the genes encoding 
these proteins is described in Ma- 
BA  se©  EIKGVKLSSMGVYPPPGSRHDKIH  terials  and  Methods.  The  arrows 
indicate where the sequences of  the 
liAIC  EIKGVKLSSHGVYPPPG$1~VGIGIGVLAIGVLVV'TilVYVVIRTSOS]tO]tH]IR  parent molecules are joined in the 
I  chimeras. The boxed sequences in- 
IIS¥-I  zzC  TEROVIEAI~WVGIGIGVLAAGVLVVTAIVYVV~TSQSRQRHRR  dicate the hydrophobic transmem- 
brane domains.  Sequences in  the chimera that differ from those of HA are in  bold type. The  amino acid sequence of HA351,  the parent 
molecule for the HAG chimera, differs from that of HA by the deletion and substitution shown; a synthetic DNA linker was inserted into the 
HA gene at that position. HA  s,  the parent molecule for HAgC, contains amino acids coded by sequences added to the HA  m gene during the 
cloning process. Five of these amino acids are retained by HAgC. 
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of HA-related glycoprotein produced by CV-1 cells infected 
with the various virus vectors was measured by radioimmu- 
noassay of culture supernatants and cell lysates; after 68 h the 
amount of each protein was equivalent to l0  s molecules per 
cell (data not shown). The chimeric proteins were detected at 
the cell surface by immunofluorescence (see below) and by 
hemadsorption. At 68 h  after infection,  100%  of CV-1 cells 
in  cultures expressing either wild-type HA or the chimeras 
bound erythrocytes. Thus, HAG and HAgC were equivalent 
to wild-type HA both in the amount of protein present at the 
cell surface and in the capacity to bind to sialic acid on red 
cells.  In experiments to be reported elsewhere, we observed 
that HAG was transported through the exocytic pathway as 
rapidly as HA. HAgC moved to the cell surface more slowly. 
In addition to the ability to bind sialic  acid,  HA has the 
capacity to induce fusion between the membrane in which it 
is anchored and another, closely apposed membrane (35, 4 l, 
67). This fusion potential is generated by a post-translational 
cleavage at a  single site in the ectodomain (see Fig.  1).  To 
determine whether HAG and HAgC retained the membrane 
fusion  activity  of wild-type  HA,  CV-I  cells  infected  with 
recombinant viruses were activated for fusion by mild trypsin 
treatment. Human erythrocyte ghosts loaded with horseradish 
peroxidase were allowed to bind to the cells (l 1). Upon brief 
treatment with medium buffered to pH 5.0, the erythrocytes 
fused with the infected CV-l  cells and delivered peroxidase 
into the cell cytoplasm. The results of such an experiment are 
shown in Fig. 2. After fixation and reaction with diaminoben- 
zidine,  cells  expressing the  chimeric  or mutant  HAs were 
stained (Fig.  2,  C-F) but uninfected controls were not (not 
shown). The pH at which fusion occurred was the same for 
both wild-type and chimeric HAs; fusion was not observed 
above pH 5.2.  Thus, HAG and HAgC bound sialic acid and 
induced  membrane fusion,  retaining both  major biological 
activities of the HA glycoprotein. 
The Ectodomains of  HAG and HAg(? Can Be 
Distinguished Immunologically from That of 
Wild- Type HA 
Although HAG and HAgC displayed the biological activities 
of HA,  we  wished  to  determine  whether  the  presence  of 
heterologous carboxy-terminal domains in the chimeras had 
influenced the HA ectodomain in some other way. Previously 
we had observed that HA  ~c, the parent molecule for the HAgC 
protein,  could  be distinguished  immunologically from  the 
wild-type HA. HA  ~  secreted into culture medium was rec- 
ognized  by an  antiserum,  designated  IH-2,  that  had  been 
raised against denatured  HA isolated by electrophoresis on 
cellulose acetate in the presence of SDS (unpublished results). 
Data summarized in Table I indicate that IH-2 serum recog- 
nizes  sites  on  the  HA  ectodomain  that  are  cryptic in  the 
mature, fully glycosylated wild-type HA. When used for im- 
Table L Specificities of  lH-2 Antiserum* 
Type of HA 
Form recognized  HA  HA  '~*  HAG  HAgC 
Tunicamycin  +  +  ND  ND 
Endo-H  s l  +  +  +  + 
Endo-H  s 2  .... 
Endo.H r  -  +  +  + 
Trypsin  ~  -  +  +  + 
Specificities of IH-2 antiserum were measured by immunoprecipitation. Tuni- 
camycin designates  the nonglycosylated  polypeptide synthesized  by cells treated 
with tunicamycin. Endo-H  s 1 refers to the form of the molecule that appears 
first during metabolic labeling with [3~S]methionine  and that contains high 
mannose oligosaccharides  sensitive to digestion with endogtycosidase  H. Endo- 
H a 2 indicates a polypeptide of slightly lower apparent molecular weight than 
endo-H  s 1 which appears after endo-H  ~ 1 during labeling and which has high 
mannose oligosaccharides  sensitive to digestion by endo-H. Endo-H  r designates 
polypeptides containing oligosaccharides  resistant to endo*H. Trypsin  ' refers to 
polypeptides that have been cleaved into HA~ and HA2 subunits by trypsin 
added to cell culture medium indicating those molecules that have reached the 
cell surface. 
* A detailed analysis of the specificities  of IH-2 antiserum will be published 
elsewhere. 
* HA  '~ is a truncated form of HA lacking the transmembrane and cytoplasmic 
domains and is secreted. 
munofluorescent  staining  of permeabilized cells  expressing 
wild-type HA, IH-2 produced a reticular pattern with none of 
the perinuclear staining characteristic of the Golgi apparatus, 
and no surface fluorescence (not shown). HA (Fig.  3, a and 
b) or HA351 (not shown) at the surface of nonpermeabilized 
cells was completely unreactive with IH-2 but was detected 
by a rabbit polyclonal serum that recognizes all forms of HA. 
By contrast, IH-2 labeled the HAG and HAgC present at the 
cell surface (Fig. 3, D and F). Thus, the ectodomains of HAG 
and HAgC differed in some way from that of wild-type HA, 
either in shape or in stability. Although the transmembrane 
and cytoplasmic domains in the chimera anchored the pro- 
teins to the cell  membrane and allowed the transport of a 
functional HA ectodomain to the cell  surface, they did not 
fully substitute for the wild-type HA domains in maintaining 
HA structure. 
HAG and HAgC Are Concentrated in Coated Pits, 
HA Is Not 
To determine whether the G and gC domains in the chimeric 
proteins would direct the HA ectodomain into the endocytic 
pathway, we compared the  extent to which the  HAG and 
HAgC localized in coated pits. In a first set of experiments, 
CV-I cells expressing wild-type HA, HAG, HAgC, or HA351 
were fixed with glutaraldehyde before immunospecific label- 
ing in order to exclude any redistribution of the proteins that 
might be induced  by cross-linking antibodies.  In a  second 
series of experiments, unfixed cells expressing the wild-type 
or chimeric proteins were labeled at 0*C and samples were 
subsequently placed into medium at 37"C to allow endocytosis 
Figure 2. The chimeric glycoproteins retain HA functions of hemadsorption and cell fusion. (A) 40 h  after infection CV-I cells expressing HA 
bind guinea pig erythrocytes. (B) CV- 1 cells expressing HAgC 40 h after infection bind erythrocytes at levels similar to those in wild-type HA. 
To demonstrate cell fusion, at 40 h  after infection cells expressing HA, HA351, HAG, or HAgC were briefly treated with trypsin to cleave the 
glycoproteins into their subunits, then allowed to bind to human erythrocyte ghosts which had been loaded with horseradish peroxidase. The 
pH of the medium was lowered to 5.0, and cell fusion delivered the peroxidase into the cytoplasm of infected cells. Cells containing peroxidase 
were stained with diaminobenzidine. (C) HA. (D) HA351. (E) HAG. (F) HAgC. Bar: A and B, 22.5 fzm; C-F, 6 ~m. 
Roth et al. Endocytosis of  Chimeric Glycoproteins  1275 Figure 3, HAG and HAgC express epitopes that are cryptic on the mature HA ectodomain. A, C, and E  show cells labeled with a rabbit IgG 
that recognizes all forms of HA. B, D, and F  show cells labeled with the IH-2 antiserum (for specificity, see Table I). (A and B) HA. (C and D) 
HAG. (E and F) HAgC. The exposure time was the same for all photographs.  Bar, 6 lzm. 
Figure 4. HA is rarely observed in coated pits.  Cells expressing HA were fixed 36 h after infection and labeled with anti-HA IgG and ferritin- 
conjugated second antibody, then processed for electron microscopy. Ferritin was often observed quite near, but not inside, coated pits, even 
on cells (A and B) that were heavily labeled over their surfaces.  Bar,  50 nm. 
to take place. No differences were observed between samples 
fixed  before  labeling  and  samples  labeled  at  0*C  (but  not 
warmed to 37"C) before fixation. As shown in Fig. 4, coated 
pits  on  cells expressing  wild-type  HA  usually  contained  no 
ferritin-conjugated antibody. Even in examples in which con- 
siderable HA was labeled at adjacent cell surfaces little ferritin 
was found in coated structures (Fig. 4, A-C). In these experi- 
ments,  cells expressing  HA351  were  indistinguishable  from 
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cifically labeled 36 h after infection.  Coated pits on these cells usually contained ferritin, regardless of whether most of the cell membrane was 
labeled (C and D) or lacked much label (A, B, E, and F). Bar, 50 nm. 
cells expressing wild-type HA (not shown). By contrast, coated 
pits on cells expressing the chimeric proteins were well labeled. 
As shown in Fig. 5, coated pits on cells expressing HAG were 
often  labeled  with  ferritin  even  when  nearby  areas  of the 
plasma membrane were not (Fig. 5, A and B), suggesting that 
HAG concentrated  preferentially in coated pits.  The surface 
distribution  of HAgC resembled that of HAG. Fig. 5, E  and 
F  present examples of cells expressing HAgC where ferritin is 
seen concentrated  in coated pits but is absent from the sur- 
rounding plasma membrane. 
The chimeric HAs were clearly observed to accumulate in 
coated pits whereas the wild-type HA appeared to be excluded 
from those structures. To quantitate this difference in surface 
distribution,  we calculated the percentage of coated pits con- 
taining  ferritin  for cells expressing each  of these  HAs.  This 
procedure gave a  very conservative estimate of the extent to 
which location in coated pits was favored for the chimeras in 
comparison to HA. Coated pits on cells expressing HAG or 
HAgC were often filled with ferritin, but such heavily labeled 
pits  were  rare  on  cells that  expressed  comparable  levels of 
wild-type  HA.  Less  than  10%  of the  coated  pits  on  cells 
expressing  wild-type  HA  scored  as  unambiguously  positive 
for ferritin.  Fig. 4D shows a  coated pit that might contain  a 
few ferritin particles and could  not be scored with certainty. 
If examples similar to this were scored as positive, the upper 
limit of coated pits on cells expressing HA, which might have 
contained  a  few ferritin  particles,  was 35%.  By contrast,  on 
cells expressing HAG ~90% were observed to be well labeled 
with ferritin. The remaining  10% could not be scored unam- 
biguously.  In parallel experiments,  ~75%  of coated pits  on 
cells expressing HAgC definitely contained ferritin. 
When  cells labeled at 0*C were warmed to  37"C  for 90  s 
before fixation, ferritin-labeled HAG was observed located in 
what appeared to be small vesicles inside cells; such vesicles 
were  more prevalent when  cells expressing either  HAgC or 
HAG were fixed after a  10-min incubation at 37"C (data not 
shown).  Endocytosis  of labeled  cell  surface  receptors  into 
vesicles of the size and morphology of those we observed has 
been reported to occur over a  similar time scale (17, 29, 44). 
Thus it appeared that both HAG and HAgC were preferen- 
tially located in coated pits as a first step in the internalization 
of those proteins. 
Chloroquine Causes HAG and HAgC to Concentrate 
at an Intracellular Site 
Agents that raise intracellular pH have been shown to inhibit 
delivery of many proteins to lysosomes and the recycling of 
many receptors to the cell surface, causing an accumulation 
of internalized  proteins  in  endosomes  (6,  23,  25,  43,  62). 
Some of these agents,  such as monensin,  significantly affect 
the  exocytic  pathway  as  well  (1,  65).  However,  we  have 
observed that moderate levels of chloroquine have little effect 
on the exocytosis of wild-type HA, HAG, or HAgC (unpub- 
lished  results).  Thus if HAG and  HAgC were  preferentially 
entering the endocytic pathway through coated pits, the pres- 
ence ofchloroquine should result in a significant intracellular 
accumulation of HAG and HAgC, but the cellular distribution 
of HA should remain unaffected. At an early period of infec- 
tion with SV40 vectors when wild-type or chimeric HAs were 
beginning to accumulate at the cell surface, chloroquine was 
added  to  the  cell  culture  medium,  and  the  cells were  then 
examined by immunofluorescent staining. Chloroquine treat- 
ment had little effect on the cellular location of HA or HA351; 
even after 12 h of treatment HA was observed predominately 
at the cell surface (Fig. 6A). Thus, the pattern of fluorescence 
in chloroquine-treated  cells expressing HA was indistinguish- 
Roth et al. Endocytosis of  Chimeric Glycoproteins  1277 Figure 6.  HAG and HAgC concentrate in vesicles in cells treated with chloroquine, but HA does not. After  12 h  of treatment with 25 •M 
chloroquine, cells expressing HA (A and B), HAG (C and D), or HAg(? (E and F) were fixed and stained by indirect immunofluorescence. A, 
C,  and  E  show  cells  labeled with  a  monoclonal  antibody that recognizes only mature  undenatured  HA,  and  an  anti-mouse fluorescein 
isothiocyanate-conjugated  second  antibody.  B,  D,  and  F  show  the  same  cells  as  on  the  left  labeled  with  1H-2  antiserum  and  with  a 
tetramethylrhodamine isothiocyanate-conjugated second antibody. Bar,  10.3 #m. able from that in cells expressing either HA, HAG, or HAgC 
in  the  absence  of chloroquine.  By  contrast,  chloroquine 
caused a progressive  loss of HAG or HAgC from the plasma 
membrane and a concomitant appearance of large, intracel- 
lular vesicles that stained with antibodies to HA. In cultures 
expressing  HAG, these vesicles were observed after only 3 h 
in  medium  containing  chloroquine;  by  6  h  of treatment 
vesicles were observed in most cells (results not shown). Cells 
expressing  HAgC displayed similar patterns of fluorescence 
although the accumulation of vesicles was slower (results not 
shown).  After 12 h of treatment with chloroquine >90% of 
cells expressing  either HAG (Fig. 6, C and D) or HAgC (Fig. 
6,  E  and F) had  significantly  reduced surface staining and 
contained numerous large  vesicles  that  react  with  anti-HA 
antibodies.  It was important to establish  that the fluorescent 
vesicles observed in cells treated with chloroquine were  not 
derived from the Golgi apparatus or some other compartment 
of the exocytic pathway. Thus, in a control experiment cyclo- 
heximide at a level sufficient  to abolish protein synthesis  in 
CV-I cells (100 ~g/ml) was added to cells expressing  HA or 
the chimeric proteins 3 h before the addition of chloroquine. 
Under these conditions the fluorescence was reduced in inten- 
sity but the pattern was not changed (data not shown); the 
main perturbation of transport of HAG and HAgC occurred 
during endocytosis. 
To determine whether HAG or HAgC in intracellular ves- 
icles represented denatured proteins cleared  from the plasma 
membrane, cells were  stained  using a  monoclonal antibody 
that reacts only with mature terminally glycosylated HA. This 
antibody  recognizes  HA  at  the  cell  surface  but  does  not 
recognize denatured HA or unfolded HA in the endoplasmic 
reticulum (unpublished results). To locate any HAG or HAgC 
that did  not react with  the  monoclonal antibody, the cells 
were double labeled with polyclonal antibody IH-2. Fig. 6, A, 
C, and E present cells stained with a goat anti-mouse IgG that 
reacts  with the monoclonal antibody, whereas  B,  D,  and E 
display the same cells stained with an anti-rabbit conjugate 
that reacts  with IH-2. HAG and HAgC in the large vesicles 
observed in  chloroquine-treated cells were  labeled  with  the 
monoclonal antibody that recognizes only the fully processed, 
mature  wild-type HA (Fig.  6,  C  and  E).  Thus,  HAG and 
HAgC molecules with  a  native conformation were internal- 
ized,  indicating  that  endocytosis of the  chimeras  involved 
more than the clearance of denatured proteins from the cell 
surface. 
In the absence of chloroquine the pattern of immunoflu- 
orescent staining of HAG resembled that of cells expressing 
wild-type HA. For both wild-type  HA and HAG most of the 
protein was observed to be at the cell surface. Thus, we could 
find no indication that internalized HAG was collecting at an 
intracellular site.  Nor did we observe increased degradation 
of HAG, which would suggest that internalized protein was 
being  delivered  to  lysosomes.  When  HA  and  HAG  were 
metabolically labeled  with [35S]methionine  for 15 min at 36 
h after infection, no difference  was observed in the amount 
of  protein immunoprecipitated immediately after the labeling 
period and the amount precipitated after the cells had been 
maintained in culture for an additional 20 h (data not shown). 
These  observations are  consistent  with  the  possibility  that 
HAG was returning  to  the  cell  surface quite  rapidly after 
endocytosis. 
HAG and HAg(? Are Rapidly Internalized 
To determine the rate of internalization of HAG and HAgC, 
we measured the rate at which HAG and HAgC labeled  at 
the cell surface became inaccessible  to protease added to cell 
culture medium. The surfaces of  cells expressing HA, HA351, 
HAG, or HAgC were labeled  with  1251 at 0*C. When trypsin 
was added to the cell culture medium at this point, the labeled 
HAs were  quantitatively processed  into HA1 and HA2 sub- 
units  because  no  internalization  had  occurred.  HAG and 
HAgC can be detected in coated pits at this temperature (Fig. 
5),  and thus clustering  in  endocytic pits  at the cell  surface 
does not render these HAs inaccessible to extracellular  trypsin. 
However, when labeled CV-I cells expressing HAG or HAgC 
were incubated at 37"C for 5 or 10 min to allow endocytosis 
to occur, subsequent trypsin treatment at 0*C did not cleave 
all of the chimeric glycoproteins.  In parallel  experiments,  no 
uncleared HA or HA351  was observed even after chases of 
60 min at 37°C (not shown).  The results of one such experi- 
ment with HA and HAG are shown in Fig. 7. As shown in 
the autoradiograph of the upper gel, wild-type  HA was not 
protected from trypsin cleavage after l0 min chase at 37°C, 
although by 120 min a trypsin-resistant,  69-kD polypeptide 
representing  uncleaved HA was  observed.  By contrast,  the 
trypsin-resistant  HAG 7 l-kD band  appeared  after a  5-min 
chase  at  37"C. In  similar  experiments,  a  trypsin  resistant 
Figure 7.  Internalization of chimeric proteins protects them from 
trypsin cleavage. At 36 h after infection CV-1 cells expressing either 
chimeric or wild-type HA were labeled with t251 at 0*C, a temperature 
that does not permit endocytosis  (61). After extensive washing, cells 
were either left on ice or incubated at 37"C for periods as brief as 5 
min. The cells were returned to medium at 0*C, and some samples 
were treated with 100 #g/ml trypsin for 1 h. HA at the cell surface 
was quantitatively cleaved into HAt and HA2 subunits. HAs that had 
been internalized, however, would have been inaccessible to  the 
trypsin and remained uncleared. After processing  by immunoprecip- 
itation, PAGE, and autoradiography, uncleaved HA and HAG mi- 
grated as bands of 69 or 71 kD, respectively. The cleaved subunits, 
HAt and HA2 or HA2G, form the major bands migrating lower in 
the gels in the lanes marked +. The uncleaved portion of HAG is 
visible as the 71-kD band in the center two lanes of the lower  gel. 
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5 min at 37"C  10 min at 37"C 
HA  0  0 
HAG  13 +_ 3  16 +  2 
HAgC  7 +__  1  8 --- 0 
The table presents the percentage  of each  molecule that remained uncleaved 
by trypsin added after a chase at 37"C for the period shown. 
HAgC  band  was  also  observed  after  a  5-min  chase  (not 
shown). 
To  determine  the  amount  of HA,  HAG,  or  HAgC  that 
became resistant to trypsin digestion during the  chase,  the 
HA, HAl, and HA2 bands were cut from gels, and the radio- 
activity  present  in  the  gel  slices  was  measured.  Table  II 
presents the initial percentages of HA, HAG, and HAgC that 
became inaccessible to extracellular trypsin after 5 or I0 min 
chase at 37"C. During the first  10 min of the chase HA was 
completely cleaved,  indicating  that  no  internalization  had 
occurred. After a long chase of 120 min, uncleaved wild-type 
HA was detected at a  level of 10%.  By contrast,  ~15%  of 
HAG and ~7% of HAgC became protected after only 5 min. 
Thus, HAG, and HAgC appeared to be rapidly internalized 
but at different rates. The percentage of HAG that was inac- 
cessible to trypsin digestion remained constant for the first 30 
min of chase and thereafter declined to 2% after 60 rain. No 
similar decline  in  the  amount of protected  HAgC was ob- 
served. The rate ofendocytosis through coated pits is sufficient 
to internalize 50-150%  of the plasma membrane each hour 
(9, 38, 60). Thus, the rate of internalization of HA of 5% per 
h  represents a significant exclusion of that protein from the 
endocytic pathway. By contrast, the rate for HAG of 1.5% 
per rain is within the range of rates of internalization mea- 
sured for cell  surface receptors in the  absence of ligand (6, 
31). 
In the bottom of Fig. 7, the outside lanes of the gel contain 
bands from the immunoprecipitation of samples of HAG that 
were not treated with trypsin. Nevertheless, bands migrating 
at the positions of HA~ and HA2 can be seen in these lanes. 
During  experiments analyzing the  kinetics of exocytosis of 
HAG and HAgC (to be reported elsewhere), we observed that 
both of those molecules were cleaved by endogenous proteases 
on CV-l  cells,  whereas there was little endogenous cleavage 
of wild-type HA. Although the pattern of  endogenous cleavage 
of the various HAs does parallel the pattern of endocytosis, 
at present we know only that  most of this cleavage occurs 
after HAG and HAgC arrive at the cell  surface. Obviously, 
the  proportion  of the  chimeric  proteins  that  was  cleaved 
before surface labeling would  not have scored in  our inter- 
nalization assay, and thus the rates of internalization of HAG 
and HAgC may be higher than reported above. 
Whether labeled by iodination at the cell surface or during 
synthesis  with  [35S]methionine,  the  HAl  subunits  of both 
HAG and HAgC migrate as diffuse bands on polyacrylamide 
gels,  leading to the  impression that less  material is present. 
However, the ratio of 125I radioactivity in HAl to that in HA2 
was not significantly different for the chimeric proteins (0.29) 
than for the wild-type HA (0.25).  Thus the HAl subunits of 
HAG and HAgC were not selectively degraded by the trypsin 
digestion used to generate them. At present, we do not know 
the cause of this difference in mobility during electrophoresis. 
Discussion 
Two chimeric HA glycoproteins, HAG and HAgC, containing 
the large external domain of the HA of influenza virus and 
foreign transmembrane and cytoplasmic domains, were effi- 
ciently expressed at the surface of cells infected with recom- 
binant SV40 vectors. The chimeric HAs retained the biolog- 
ical functions of the wild-type protein. However, by several 
criteria HAG and HAgC were observed to enter the endocytic 
pathway,  whereas HA was essentially excluded.  (a) Coated 
pits on cells expressing the chimeric glycoproteins were much 
more frequently  labeled  with  anti-HA  antibody,  and  were 
labeled to a  much greater extent, than coated pits on cells 
expressing wild-type HA. HAG and HAgC appeared to locate 
preferentially in coated pits; on cells expressing these proteins 
coated pits were densely labeled even when surrounding areas 
of membrane contained  little  anti-HA antibody. (b) When 
cells expressing HA, HAG, or HAgC were treated with levels 
of chloroquine that allow delivery of proteins to endosomes 
but that interfere with further transport, the chimeric proteins 
accumulated in intracellular vesicles. By contrast, chloroquine 
treatment of cells expressing wild-type HA had no effect on 
the  location  of that protein.  (c) When  the  surfaces of cells 
expressing HA, HAG, or HAgC were iodinated at a temper- 
ature that prevented endocytosis (61) and the ceils were then 
incubated for 5 min at a temperature which permitted inter- 
nalization,  13% of HAG and 7% of HAgC became inacces- 
sible to digestion by trypsin. Under the same conditions, HA 
remained completely sensitive to trypsin even after extended 
periods of incubation at a temperature permissive for endo- 
cytosis.  The rate at which HAG and HAgC acquired protec- 
tion from trypsin was similar to the rates of internalization 
reported for many cell surface receptors (6,  25,  57),  and  a 
simple interpretation of this result is that internalization of 
the chimeric glycoproteins protected them from trypsin in the 
culture medium. 
The rate of internalization of HAG would be sufficient for 
the  uptake of the  entire surface population  of that  protein 
within 1 h, Yet in the absence ofchloroquine treatment, there 
was no observable accumulation of HAG in vesicles within 
the  cell  and the  vast majority of HAG was present  at the 
plasma  membrane.  Moreover,  the  rate  of degradation  of 
[35S]methionine-labeled  HAG was  slow,  similar  to  that  of 
wild-type HA (the half-life of HAgC was noticeably shorter). 
Thus,  internalized  HAG did  not  appear to  be  targeted  to 
lysosomes. It is reasonable to assume that HAG was recycling 
to the cell surface. We conclude that the chimeric glycopro- 
teins HAG and HAgC are specifically routed into the endo- 
cytic pathway and that HAG, at least, mimics a cell surface 
receptor in recycling to the cell surface. 
We do not know whether changes in the ectodomains of 
HAgC  and  HAG  result  in  their  internalization,  perhaps 
through increased clustering of those molecules, or whether 
the  transmembrane and/or  cytoplasmic domains  of the  G 
protein and the gC protein contain  features that direct the 
HA  ectodomain  into  coated  pits.  However,  several recent 
observations suggest  that  the  latter  possibility is  the  more 
likely.  VSV G  protein has been reported to be internalized 
and to recycle when implanted into the cell surface by the 
fusion of the viral envelope with the plasma membrane (40, 
46-48).  In recent experiments in  which  G  protein was ex- 
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treatment caused the accumulation of G in vesicles (Gottlieb, 
T., M. Rindler, and D. D. Sabatini, personal communication). 
Thus, in the case of HAG an activity of G protein appears to 
be transferred to the chimera. For HAgC the situation is less 
clear, since the HSV-1 gC protein expressed in the absence of 
other HSV-1  viral proteins did not appear to reach the cell 
surface (61) and endocytosis of gC has not been reported. 
The HA glycoprotein, whether expressed from SV40 vectors 
during  lytic  infection  of CV-1  cells  (18)  or  from  bovine 
papilloma virus vectors in continuous mouse cell lines (54), 
has a long residence time on the cell surface (Copeland, C., 
A. Helenius, I. Mellman, and J. Hearing, personal commu- 
nication). In CV- 1 cells <5 % of HA was internalized per hour, 
whereas internalization of plasma membrane through coated 
pits occurs at a rate  10 to  15 times greater (2,  38,  59).  Thus 
HA was excluded from internalization  by coated pits.  The 
failure of HA to enter the endocytic pathway could not be 
caused by HA binding to sialic  acid residues on cell surface 
glycoproteins which were themselves excluded from coated 
pits. HAG and HAgC both contain the HA ectodomain and 
both bound  sialic  acid on erythrocytes as well as does HA, 
and yet they were efficiently internalized. Rather than being 
prevented from entering coated pits,  it is possible that  HA 
lacks features that allow it to be trapped by elements of the 
pits.  The inefficient uptake of HA would thus be due to the 
relatively brief residence time for HA in the coated pit. 
It is important to mention that the three-dimensional struc- 
ture for HA was solved only for the HA ectodomain, which 
had been isolated as a bromelain cleavage fragment lacking 
the 10 carboxy-terminal residues of the ectodomain, the trans- 
membrane domain, and the cytoplasmic domain (68).  The 
10 amino acids of the ectodomain proximal to the hydropho- 
bic transmembrane domain do not appear to be important 
for HA structure, since a mutant HA, HA351, which retains 
only five of these residues, is wild-type by every test at our 
disposal. The roles played by the transmembrane and cyto- 
plasmic domains of HA in maintaining the structure of the 
HA ectodomain are not well understood. The effect of alter- 
ation or deletion of the HA cytoplasmic domain was recently 
investigated;  removal of this  domain  doubled  the  average 
time required for newly synthesized Japan HA to reach the 
cell  surface but was not demonstrated to  have other effect 
(unpublished  results).  Substitution  of the  HA  cytoplasmic 
domain with that of another glycoprotein had no observable 
effect on HA function (12).  The present report extends these 
observations to  HAs containing  foreign transmembrane as 
well as cytoplasmic domains. Although HAgC moves through 
the exocytic pathway more slowly than HA (21)  HAG was 
transported  to  the  cell  surface  as  rapidly  as  the  wild-type 
protein (manuscript in preparation) and was turned over with 
the same, slow kinetics. HAG and HAgC both retained the 
biological activities of the HA molecule. Thus in  major re- 
spects two different transmembrane domains could substitute 
for that of HA. However, this substitution was not complete, 
since at the cell surface the chimeric proteins were recognized 
by  an  antiserum  that  binds  epitopes  that  are  cryptic  on 
terminally glycosylated wild-type HA. HAG and HAgC at the 
plasma  membrane were  also  recognized  by a  monoclonal 
antibody that reacts solely with the mature form of the wild- 
type HA and does not bind to the denatured glycoprotein. 
Both antisera recognized the chimeric glycoproteins that ac- 
cumulated in vesicles in chloroquine treated cells.  The fact 
that no loss of biological function was observed for the chi- 
mera, and  in  the case of HAG,  no increase in the  rate of 
degradation,  argues  against  the  existence  of two  separate 
populations of HAG and HAgC at the cell surface. Thus, the 
antigenic difference between the chimera and HA could be 
due to increased flexibility in the chimera, transiently expos- 
ing antigenic sites,  or might reflect some subtle,  more per- 
manent difference in the shape of their ectodomains. 
It is  attractive to  speculate  that  proteins destined  to  be 
internalized might contain some feature that is recognized by 
elements of coated pits.  Goldstein et al. have discussed the 
possibility that the cytoplasmic domains of cell surface recep- 
tors might contain a  specialized feature or sequence that is 
recognized by a component of the clathrin coat of an endo- 
cytic pit (22).  Pearse and Bretscher have proposed that rec- 
ognition could occur between the ectodomain of a  receptor 
and that of an adaptor protein which in turn is recognized on 
the cytoplasmic side of the pit by an element of the clathrin 
coat  (45).  Recently  Lehrman  et  al.  have  reported  results 
suggesting  that the cytoplasmic domain of the LDL receptor 
contains  features  important  for the  internalization  of that 
protein (33). Although topographically the glycoproteins de- 
scribed in the present report resemble cell surface receptors 
such  as  the  LDL  receptor,  they  have  much  smaller cyto- 
plasmic domains.  If there  were  a  highly  conserved  signal 
required for efficient localization into coated pits, one might 
assume that it would be more obvious in a context of <30 
amino acids. Although the sequences of the cytoplasmic do- 
mains  of the  gC  and  G  proteins are  both  highly charged 
compared to the  same region of HA (see  Fig.  1),  they are 
quite  different from one another and do  not  resemble the 
cytoplasmic domains of cell surface receptors known to be 
internalized through coated pits (13,  14, 42, 66, 70). Interest- 
ingly, when analyzed by the hydropathy program of Kyte and 
Doolittle (32),  the transmembrane domains of both gC and 
G  resemble the very hydrophobic and relatively short trans- 
membrane domains of the cell surface receptors. By the same 
analysis the transmembrane domains of several subtypes of 
HA are longer and  less  hydrophobic than  those  of surface 
receptors,  G,  or gC.  It is conceivable that  transmembrane 
domains of receptor proteins pack into some ordered array 
within a coated pit which greatly increases the probability that 
those proteins will be internalized. In a sense,  the macromo- 
lecular structure of  the pit itself  would function to "recognize" 
those proteins destined for endocytosis. 
Our experience indicates that the HA transmembrane or 
cytoplasmic domain can be substituted with that of another 
glycoprotein with  minimal  effect  on  the  HA  ectodomain. 
Using the techniques of site directed mutagenesis and further 
gene splicing,  we will be able to construct a series of chimeric 
HAs containing progressively fewer foreign amino acids and 
in this way locate sequences that direct the HA ectodomain 
into the endocytic pathway. Knowledge of the topology of the 
interaction that specifies the internalization of a protein will 
in turn  have important implications for understanding  the 
mechanisms controlling endocytosis through coated pits. 
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